Carroll Financial Associates’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Carroll Financial Associates’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-270	Closed	-$16K	–	1685
2020 Q4	$16K	Buy	+270	New	+$15.4K	﹤0.01%	980
2020 Q3	–	Sell	-5,148	Closed	-$264K	–	1573
2020 Q2	$264K	Buy	+5,148	New	+$259K	0.02%	293
2019 Q2	–	Sell	-2,919	Closed	-$149K	–	1628
2019 Q1	$149K	Buy	+2,919	New	+$145K	0.01%	372

Other funds holding IHE

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Carroll Financial Associates's IHE Position: Q1 2021 in Review

Carroll Financial Associates sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2021, closing a stake of 270 shares — an estimated $16K sold.

Carroll Financial Associates first reported a position in IHE in Q1 2019 and held it in 3 quarters. The position peaked at $264K in Q2 2020. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2021.

Carroll Financial Associates reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2021 after selling out during the quarter.
Carroll Financial Associates sold 270 iShares US Pharmaceuticals ETF shares in Q1 2021, an estimated $16K.
Carroll Financial Associates first reported a position in iShares US Pharmaceuticals ETF in Q1 2019 and held it in 3 quarters.
Carroll Financial Associates's iShares US Pharmaceuticals ETF position peaked at $264K in Q2 2020.
101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2021.

Based on Carroll Financial Associates's 13F filing for Q1 2021, filed 6 Apr 2021.